HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Faculty of Pharmaceutical Sciences >
Peer-reviewed Journal Articles, etc >

Therapeutic Assessment of Cytochrome C for the Prevention of Obesity Through Endothelial Cell-targeted Nanoparticulate System

Files in This Item:
Manuscript final ver.pdf785.04 kBPDFView/Open
Supplementary Text and Figures121105.pdf2.72 MBPDFView/Open
Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/54513

Title: Therapeutic Assessment of Cytochrome C for the Prevention of Obesity Through Endothelial Cell-targeted Nanoparticulate System
Authors: Hossen, Md. Nazir Browse this author
Kajimoto, Kazuaki Browse this author →KAKEN DB
Akita, Hidetaka Browse this author
Hyodo, Mamoru Browse this author
Ishitsuka, Taichi Browse this author
Harashima, Hideyoshi Browse this author →KAKEN DB
Issue Date: Mar-2013
Publisher: Nature Publishing Group
Journal Title: Molecular Therapy
Volume: 21
Issue: 3
Start Page: 533
End Page: 541
Publisher DOI: 10.1038/mt.2012.256
Abstract: Because the functional apoptosis-initiating protein, cytochrome C (CytC) is rapidly cleared from the circulation (t(1/2) (half-life): 4 minutes), it cannot be used for in vivo therapy. We report herein on a hitherto unreported strategy for delivering exogenous CytC as a potential and safe antiobesity drug for preventing diet-induced obesity, the most common type of obesity in humans. The functional activity of CytC encapsulated in prohibitin (a white fat vessel-specific receptor)-targeted nanoparticles (PTNP) was evaluated quantitatively, as evidenced by the observations that CytC-loaded PTNP causes apoptosis in primary adipose endothelial cells in a dose-dependent manner, whereas CytC alone did not. The delivery of a single dose of CytC through PTNP into the circulation disrupted the vascular structure by the targeted apoptosis of adipose endothelial cells in vivo. Intravenous treatment of CytC-loaded PTNP resulted in a substantial reduction in obesity in high-fat diet (HFD) fed wild-type (wt) mice, as evidenced by the dose-dependent prevention of the percentage of increase in body weight and decrease in serum leptin levels. In addition, no detectable hepatotoxicity was found to be associated with this prevention. Thus, the finding highlights the promising potential of CytC for use as an antiobesity drug, when delivered through a nanosystem.
Type: article (author version)
URI: http://hdl.handle.net/2115/54513
Appears in Collections:薬学研究院 (Faculty of Pharmaceutical Sciences) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 原島 秀吉

Export metadata:

OAI-PMH ( junii2 , jpcoar )

MathJax is now OFF:


 

 - Hokkaido University